Prostaglandin E2 and the renin-angiotensin system in primary aldosteronism and Cushing's syndrome. 1985

J Kuylenstierna, and B E Karlberg

8 patients with primary aldosteronism (PA) and 4 women with Cushing's syndrome (CS) were investigated with estimations of prostaglandin E2 (PGE2), plasma renin activity (PRA), and angiotensin-II (A-II) concentrations in renal venous blood, under resting and strictly standardized conditions and without pharmacological influence. In the PA group all hormone values were extremely low, but with a tendency to higher PRA and A-II concentrations in patients with idiopathic adrenal hyperplasia. Such low PGE2 concentrations have not previously been reported, and may be the consequence of decreased concentration of circulating A-II. However, a yet unidentified mechanism for the parallel suppression of the renin-angiotensin system (RAS) and of products of arachidonic acid metabolism cannot be excluded in hypertensive states where blood pressure is mainly dependent on volume factors. The number of patients in the CS group was too small to permit definitive conclusions, but a specific pattern of the PGE2 production is probably not seen in conjunction with hypercorticism. There seemed to exist only a covariation between PGE2 concentration and the degree of activation of the RAS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011458 Prostaglandins E (11 alpha,13E,15S)-11,15-Dihydroxy-9-oxoprost-13-en-1-oic acid (PGE(1)); (5Z,11 alpha,13E,15S)-11,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid (PGE(2)); and (5Z,11 alpha,13E,15S,17Z)-11,15-dihydroxy-9-oxoprosta-5,13,17-trien-1-oic acid (PGE(3)). Three of the six naturally occurring prostaglandins. They are considered primary in that no one is derived from another in living organisms. Originally isolated from sheep seminal fluid and vesicles, they are found in many organs and tissues and play a major role in mediating various physiological activities. PGE
D012083 Renin A highly specific (Leu-Leu) endopeptidase that generates ANGIOTENSIN I from its precursor ANGIOTENSINOGEN, leading to a cascade of reactions which elevate BLOOD PRESSURE and increase sodium retention by the kidney in the RENIN-ANGIOTENSIN SYSTEM. The enzyme was formerly listed as EC 3.4.99.19. Angiotensin-Forming Enzyme,Angiotensinogenase,Big Renin,Cryorenin,Inactive Renin,Pre-Prorenin,Preprorenin,Prorenin,Angiotensin Forming Enzyme,Pre Prorenin,Renin, Big,Renin, Inactive
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D003480 Cushing Syndrome A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent. Cushing's Syndrome,Hypercortisolism,Syndrome, Cushing,Syndrome, Cushing's
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

J Kuylenstierna, and B E Karlberg
January 1981, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
J Kuylenstierna, and B E Karlberg
January 1980, Hypertension (Dallas, Tex. : 1979),
J Kuylenstierna, and B E Karlberg
December 1983, Endocrinologia japonica,
J Kuylenstierna, and B E Karlberg
January 1983, Hormone research,
J Kuylenstierna, and B E Karlberg
January 1981, Endokrynologia Polska,
J Kuylenstierna, and B E Karlberg
May 1973, Nihon Naibunpi Gakkai zasshi,
J Kuylenstierna, and B E Karlberg
January 1987, Advances in prostaglandin, thromboxane, and leukotriene research,
J Kuylenstierna, and B E Karlberg
September 1980, Japanese heart journal,
J Kuylenstierna, and B E Karlberg
January 2006, Hypertension research : official journal of the Japanese Society of Hypertension,
J Kuylenstierna, and B E Karlberg
January 1996, Ryoikibetsu shokogun shirizu,
Copied contents to your clipboard!